Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine.

Mihee KimSeo-Yeon AhnTaeHyung KimSung-Hoon JungGa-Young SongDeok-Hwan YangJe-Jung LeeMi Yeon KimJu Heon ParkMyung-Geun ShinJae-Sook AhnHyeoung-Joon KimDennis Dong Hwan Kim

Published in: Hematology (Amsterdam, Netherlands) (2024)

In conclusion, the revised ELN-2022 risk stratification model may have improved the risk classification of elderly AML patients treated with hypomethylating agents compared to the ELN-2017 risk stratification model.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
middle aged
machine learning
community dwelling
deep learning
newly diagnosed